KpATCC43816 Protein target profile

glyoxalase/Bleomycin resistance /Dioxygenase superfamily protein

Accession: VK055_4114

Gene: AIK82660.1 3D evidence: AlphaFold DB model + ColabFold model Metabolism Not in network UniProt A0A0H3GXF4
Length 308
Pocket druggability (P2Rank · AlphaFold DB model) 0.9
Direct ligand evidence 0 58 total records
Functional annotation 0 EC 0 GO
Target summary

Promising target candidate with multiple supporting evidence streams.

Automated synthesis of the evidence currently loaded. Review the underlying records before prioritizing this protein.

Terms and data sources used on this page

PDB: experimentally determined structures from the Protein Data Bank. These are the strongest structural evidence, but may cover only part of the protein.

AlphaFold DB model: a precomputed predicted structure downloaded from AlphaFold Database/UniProt, not an experiment performed here.

ColabFold model: a predicted structure generated for this workspace; interpret it with coverage and confidence.

pLDDT: confidence score for predicted structures. High values support local geometry; low values mean the region should not drive pocket interpretation.

FPocket / P2Rank: software tools that predict possible ligand-binding pockets on a 3D structure. They are useful screening signals, not experimental validation.

Druggability: a pocket-based estimate of whether a small molecule could bind productively. It does not mean a drug already exists.

PDB ligand: a compound observed in an experimental structure. Direct same-protein records are stronger than homolog-transferred records.

ChEMBL: a public database of measured compound bioactivity. Direct entries are stronger than entries transferred from similar proteins.

ZINC: a purchasable-compound database. Here it marks proposed candidates from chemical similarity, not measured binders.

LigQ / LigQ_2: an internal Target pipeline step that gathers PDB, ChEMBL, and ZINC ligand evidence for each protein.

Off-target: sequence similarity to proteins we prefer not to hit, such as human proteins or beneficial gut microbiome proteins.

DEG: Database of Essential Genes. A match suggests the protein resembles genes known to be essential in other organisms.

Roary / CoreCruncher: pan-genome tools used to decide whether a gene is core across analyzed strains or accessory/strain-specific.

EC / GO: functional annotations: EC describes enzyme reactions; GO describes biological process, molecular function, or cellular component.

KEGG pathway: a curated metabolic route label used here to group reactions imported from the metabolic model.

Chokepoint: a metabolic reaction that is the only producer or consumer of a metabolite in the imported model.

Prioritization evidence

Selectivity, essentiality, structural confidence, conservation, and predicted binding-site evidence.

Off-target risk

Human off-target
No hit
Gut microbiome similarity
0.7% of screened genomes Lower prevalence suggests narrower overlap with the screened gut microbiome.

Essentiality

Essential (DEG)
N
DEG identity (%)
0.0 Higher values support similarity to known essential genes.

Structure confidence

ColabFold pLDDT
95.83 0-100 confidence; >70 supports local structural interpretation.

Binding-site evidence

AlphaFold DB / UniProt model

P2Rank's binding-site probability is the primary druggability signal shown across the app; FPocket's druggability score is shown alongside it for comparison. Both estimate small-molecule pocket quality after applying the curated structure priority — neither is experimental binding evidence. The 3D viewer may show a different loaded structure, so visible pockets can differ.

Druggability (P2Rank) 0.9
Structure A0A0H3GXF4
Pocket Pocket 1
Druggability (FPocket) 0.74
Structure A0A0H3GXF4
Pocket Pocket 8
ColabFold model
P2Rank 0.921 · Pocket 1
FPocket 0.962 · Pocket 8
Core conservation Accessory gene
Roary accessory
CoreCruncher accessory
Gut microbiome 33 / 4744 genomes with a hit
Prevalence 0.7%

Metabolic context

Reactions catalyzed, pathway membership, and centrality in the genome-scale metabolic network.

This protein is not associated with the imported metabolic network for this genome.

Browse the genome's metabolic network

Imported from KpATCC43816.sbml · 2026-07-09

Sequence

Primary amino-acid sequence viewer.

MSITGIEKLEFGVDDLNHSAKFMRDFGLTGDASGRAFTTLSGARVELNPTDAANLPPAFEAGNTLRRMTWGVADRAALDALRPKLERQPAFREIDGALECRDPNGMTLRVQVSQQTAVELNVEPINQWGDVRRIDTPSPVYDRAQPINVGHVVFFVEELAAVESFYREVLGFQVSDRYINRAVFLRCGVRGGHHNLFLLQLPNRKRGLNHVAFTVRDIHEVIGGGIAMNKNAWSTFIGPGRHPVSSAYFWYVNSPTGGAFEYYTNDDYLTENWQPRELEHSLVSFTEWAVEGGIDHDTRRQQKKPEAV

Functional annotations

Enzyme classification and Gene Ontology terms linked to this protein.

Subcellular localization

Localization
Cytoplasmic

No GO or EC annotations are currently loaded for this protein.

Sequence domains and features

Domain and signature matches imported from InterPro and related databases.

11 records
Show feature table
Start End DB Term Name
150 276 CDD cd08343 ED_TypeI_classII_C
144 289 Gene3D G3DSA:3.10.180.10 -
144 289 InterPro IPR029068 Glyoxalase/Bleomycin resistance protein/Dihydroxybiphenyl dioxygenase
148 265 ProSiteProfiles PS51819 Vicinal oxygen chelate (VOC) domain profile.
148 265 InterPro IPR037523 Vicinal oxygen chelate (VOC) domain
1 276 SUPERFAMILY SSF54593 Glyoxalase/Bleomycin resistance protein/Dihydroxybiphenyl dioxygenase
1 276 InterPro IPR029068 Glyoxalase/Bleomycin resistance protein/Dihydroxybiphenyl dioxygenase
1 124 Gene3D G3DSA:3.10.180.10 -
1 124 InterPro IPR029068 Glyoxalase/Bleomycin resistance protein/Dihydroxybiphenyl dioxygenase
149 262 Pfam PF00903 Glyoxalase/Bleomycin resistance protein/Dioxygenase superfamily
149 262 InterPro IPR004360 Glyoxalase/fosfomycin resistance/dioxygenase domain

3D structure

Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; AlphaFold DB and ColabFold models typically cover the full protein but remain computational predictions.

Download VMD script Full viewer

Loading 3D structure...

Drag to rotate — click the view, then scroll to zoom.

Pocket score High Medium Low
How colors and pocket overlays are used
Uniform protein color marks the displayed model as a single molecular object.
Experimental PDB structures may be colored by chain to distinguish subunits or copies present in the file.
Pocket colors and alpha spheres are evidence overlays for predicted binding cavities; they are not alternative protein chains.
'Alpha spheres' is FPocket's own cavity-shape geometry, imported when available and aligned with the loaded structure.
'Pocket atoms'/'Predicted site atoms' show the pocket's residue atoms instead: P2Rank reports residues rather than alpha spheres, and FPocket falls back to this when alpha-sphere geometry is unavailable or doesn't align.
'No pocket geometry' means neither alpha spheres nor residue-position data could be found for that pocket; the layer just highlights the same residues as 'Nearby residues'.
Pocket details Inspect a specific pocket, or open the full viewer

Binding pockets · P2Rank

Druggability (P2Rank): high ≥ 0.5 · medium 0.2–0.49 · low < 0.2

Pocket 1 P2Rank #1
0.9
Likely same site as FPocket 1 3.5 Å 12 shared residues 86% of smaller site
Show in viewer
Surrounding area
Pocket 2 P2Rank #2
0.756
Show in viewer
Surrounding area
Pocket 3 P2Rank #3
0.059
Show in viewer
Surrounding area

Binding pockets · FPocket

Druggability (FPocket): high ≥ 0.7 · medium 0.4–0.69 · low < 0.4

Pocket 1 FPocket #8
0.74
Likely same site as P2Rank 1 3.7 Å 12 shared residues 80% of smaller site
Show in viewer
Surrounding area
Pocket 2 FPocket #1
0.528
Likely same site as P2Rank 1 3.5 Å 12 shared residues 86% of smaller site
Show in viewer
Surrounding area
All structural evidence 0 experimental · 2 predicted

Structural evidence

0 + 2

Experimental PDB entries plus predicted AlphaFold DB or ColabFold models. Click Switch to display a different loaded structure in the viewer.

Entry Method Resolution Chain Coverage Links Status
AlphaFold DB AF_A0A0H3GXF4
AlphaFold DB full sequence Viewing
ColabFold VK055_4114
ColabFold full sequence Loaded

Ligand evidence

Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.

58 records
Chemistry signal

Structural ligand evidence is available for this target.

Direct evidence 0 same-protein records
Transferred evidence 8 records from similar proteins
Structural ligands 8 0 loaded crystals
Measured bioactivity 0 direct and transferred ChEMBL records
Proposed compounds 50 similarity-based ZINC candidates
Best available ligand signal
BP3 PDB via homolog 220.7 Da · LogP 3.42 · TPSA 40.5 Open detail RCSB PDB
BP6 PDB via homolog Detail RCSB PDB
BPY PDB via homolog Detail RCSB PDB
CAQ PDB via homolog Detail RCSB PDB
M3P PDB via homolog Detail RCSB PDB

Structural evidence inferred from similar proteins. The source crystal indicates where the ligand was observed; the UniProt column identifies the homologous protein carrying that ligand.

Show only:
Ligand Source crystal UniProt (homolog) MW · LogP · TPSA Lipinski PAINS SMILES
BP3 RCSB PDB P47228 220.7 Da LogP 3.42 TPSA 40.5 ✓ Ro5 Alert c1ccc(c(c1)c2cccc(c2O)O)Cl
BP6 RCSB PDB P47228 255.1 Da LogP 4.07 TPSA 40.5 ✓ Ro5 Alert c1cc(c(c(c1)O)O)c2c(cccc2Cl)Cl
BPY RCSB PDB P47228 186.2 Da LogP 2.76 TPSA 40.5 ✓ Ro5 Alert c1ccc(cc1)c2cccc(c2O)O
CAQ RCSB PDB P47228 110.1 Da LogP 1.10 TPSA 40.5 ✓ Ro5 Alert c1ccc(c(c1)O)O
M3P RCSB PDB Q7WYF5 156.1 Da LogP 0.66 TPSA 74.6 ✓ Ro5 ✓ Clean CC(=O)\C=C\C=C(/C(=O)O)\O
MBD RCSB PDB P47228 124.1 Da LogP 1.41 TPSA 40.5 ✓ Ro5 Alert Cc1cccc(c1O)O
MCT RCSB PDB Q7WYF5 124.1 Da LogP 1.41 TPSA 40.5 ✓ Ro5 Alert Cc1ccc(c(c1)O)O
TBU RCSB PDB P47228 74.1 Da LogP 0.78 TPSA 20.2 ✓ Ro5 ✓ Clean CC(C)(C)O

PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.

Cross-references

External database identifiers for this protein, its structures, ligands, and metabolic reactions.